Legend BiotechLEGN +2.42%73 Days Inventory is 17.92 as of Mar. 2026, which is 47% below its 10-year median of 33.75. GuruFocus rates LEGN with a GF Score™ of 73/100 and a GF Value™ of $98.55 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Legend Biotech ranks better than 94.04% on this metric.
The historical rank and industry rank for Legend Biotech's Days Inventory or its related term are showing as below:
LEGN'
s Days Inventory Range Over the Past 10 Years
Min: 23.47 Med: 33.75 Max: 37.7
Current: 23.47
During the past 8 years, Legend Biotech's highest Days Inventory was 37.70. The lowest was 23.47. And the median was 33.75.
LEGN's Days Inventory is ranked better than 94.04% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs LEGN: 23.47
Legend Biotech's Days Inventory
declined
from Mar. 2025 (35.09) to Mar. 2026 (17.92).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Legend Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 was 5.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Legend Biotech's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.11.
Legend Biotech (NAS:LEGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Legend Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Legend Biotech's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Legend Biotech Days Inventory Related Terms
Legend Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Legend Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LEGN vs TVTX, ORKA, CRSP: Days Inventory Comparison
For the Biotechnology subindustry, Legend Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Legend Biotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Legend Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Legend Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Legend Biotech (LEGN) has a Days Inventory of 17.92 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Legend Biotech and its competitors. This is 47% below median its historical median of 33.75. Over the past decade, Legend Biotech's Days Inventory has ranged from 23.47 to 37.70. According to the industry distribution chart, Legend Biotech ranks #38 out of 638 companies in the Biotechnology industry, placing it in the top 6%.
Is Legend Biotech's Days Inventory too high?
Legend Biotech's current Days Inventory of 17.92 is 47% below median its 10-year median of 33.75. Over the past 10 years, this metric has ranged from a low of 23.47 to a high of 37.70. The Biotechnology industry median Days Inventory is 183.88. Legend Biotech's value of 17.92 is 90.3% below this industry median. Based on the distribution chart, Legend Biotech ranks #38 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Legend Biotech has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Legend Biotech's Days Inventory compare to TVTX and ORKA?
According to the Biotechnology industry distribution chart, Legend Biotech ranks #38 out of 638 companies for Days Inventory. This places Legend Biotech in the top 6% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.88. Legend Biotech's value of 17.92 is 90.3% below this benchmark. Historically, Legend Biotech's own Days Inventory has ranged from 23.47 to 37.70 over the past decade. While the company's 10-year median is 33.75 vs. the industry median of 183.88, Legend Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Legend Biotech's current Days Inventory of 17.92 is 90.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Legend Biotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Legend Biotech's current Days Inventory is 17.92, which is 47% below median its own 10-year median of 33.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legend Biotech stock overvalued right now?
Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Possible Value Trap. The stock's GF Value™ is $98.55, compared to a current price of $29.37 — trading 70.2% below its estimated fair value. The current Days Inventory is 17.92, which is 47% below median its 10-year median of 33.75 and 90.3% below the Biotechnology industry median of 183.88. Legend Biotech's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Days Inventory is 17.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Legend Biotech (LEGN) Overvalued in 2026?
Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued.
The current stock price of $29.37 is trading 70.2% below its estimated GF Value™ of $98.55.
GuruFocus considers Legend Biotech to be Possible Value Trap.
Key valuation signals for LEGN:
Days Inventory: 17.92 (47% below median its 10-year median of 33.75)
GF Value™: $98.55 vs. price of $29.37 (70.2% below fair value)
Industry Position: 90.3% below the Biotechnology median (#38 of 638)
No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
73GF Score
Get the complete analysis for LEGN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEGN has been successfully added to your 
